跳至主要内容
临床试验/NCT04887155
NCT04887155已完成不适用

Mobile-enhanced Transdiagnostic Group Treatment for Adolescents at Risk for Severe Mood Disorders

University of California, Los Angeles2 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2021年8月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
2
主要终点
Treatment Skill Practice

研究概览

简要总结

Although cognitive-behavioral therapy (CBT) has shown efficacy in reducing symptoms and rates of mood relapse in adolescents at high risk for severe mood disorders (SMD; i.e., bipolar I/II disorder and recurrent or unremitting major depression), a significant limitation to the CBT's efficacy is the low rate of participant adherence to the prescribed between-session homework tasks. Mobile health applications have the potential to improve adherence to and acceptance of treatment through embedded treatment content, skill-practice, thought and symptom monitoring, all of which are facilitated by reward contingencies and notifications. This study examines whether a mobile application-enhanced CBT can improve participant adherence and treatment acceptance for adolescents at high risk for SMD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
13 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Meet DSM-5 criteria for at least one past major depressive disorder, persistent depressive disorder, or unspecified bipolar disorder
  • Be 13-17 years old
  • English speaking and able to complete written questionnaires
  • Ability to attend pre-determined group session time(s)
  • Access to a smartphone to engage with the study app
  • Medication usage is acceptable, but not required

排除标准

  • Regular use or current abuse of a psychoactive drug
  • Evidence of behavioral problems that are thought to interfere with group treatment
  • Suicidality that requires more intensive treatment
  • Meeting DSM 5 criteria for bipolar I or II disorder, a psychotic disorder, or significant psychiatric symptoms (e.g., self-injurious behavior) that require more intensive treatment
  • Concurrent participation in cognitive-behavioral therapy
  • Inability to travel to study sessions and assessments

结局指标

主要结局

Treatment Skill Practice

时间窗: 9-week treatment period

Sum of all treatment skill practices completed through the course of the treatment (based on adolescent report).

Psychosocial Treatment Compliance Scale

时间窗: 9-week treatment

Clinician-rated of participant overall treatment compliance. Scores range from 17-85 (17 5-point Likert scale items) with higher scores indicating greater treatment compliance.

Mobile Application Use

时间窗: 9-week treatment period

Frequency of mobile application (app) usage within the condition that received the mobile application, ranging from 0 to unlimited maximum with higher scores indicating more app usage.

次要结局

  • Mobile Application Usability Scale(Measured at the end of the 9-week treatment period)
  • Children's Depression Rating Scale, Revised(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Young Mania Rating Scale(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Clinical Global Assessment Scale(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Clinical Global Impression(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Symptom Checklist 90(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Difficulties With Emotion Regulation(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • KINDL(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)
  • Depression Anxiety & Stress Scale(Measured prior to treatment (0 months), at the end of the 9-week treatment, and the end of the 21-week study period.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marc J. Weintraub, PhD

Principal Investigator

University of California, Los Angeles

研究点 (2)

Loading locations...

相似试验